Nevro Corp.

The momentum for this stock is not very good. Nevro Corp. is a mediocre stock to choose.

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that...

News

Nevro Corp. (NYSE:NVRO) Given Average Recommendation of "Reduce" by Analysts

Ticker Report Shares of Nevro Corp. (NYSE:NVRO - Get Free Report) have earned a consensus recommendation of "Reduce" from the fourteen brokerages that are covering the stock, MarketBeat reports. Three analysts...\n more…

Nevro price target lowered by $10 at BofA, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Nevro Corp: Underperform Rating with Reduced Price Objective Amid Revenue Decline and Market Challenges

TipRanks Financial Blog In a report released on August 30, Travis Steed from Bank of America Securities reiterated a Sell rating on Nevro Corp (NVRO - Research Report), wi...\n more…

Nevro to Present at Wells Fargo 2024 Healthcare Conference

PR Newswire Nevro to Present at Wells Fargo 2024 Healthcare Conference Nevro to Present at Wells Fargo 2024 Healthcare Conference PR Newswire REDWOOD CITY, Calif., Aug. 28, 2024 REDWOOD CITY, Calif., Aug. 28...\n more…

Nisa Investment Advisors LLC Has $58,000 Stock Holdings in Nevro Corp. (NYSE:NVRO)

Ticker Report Nisa Investment Advisors LLC lifted its stake in shares of Nevro Corp. (NYSE:NVRO - Free Report) by 1,788.8% during the second quarter, according to the company in its most recent filing with the...\n more…

Nevro (NYSE:NVRO) Lowered to "Sell" at StockNews.com

Ticker Report Nevro (NYSE:NVRO - Get Free Report) was downgraded by equities research analysts at StockNews.com from a "hold" rating to a "sell" rating in a note issued to investors on Wednesday. A number of other...\n more…